In vitro experiments revealed that GPNCA silencing markedly inhibits tumor cell proliferation via regulation of GSK3B, suggesting that drugs targeted to GPNCA may hold potential considerable value for anti-cancer therapy. This evidence concerns the gene GSK3B and neoplasm.